EICHORCondition: Squamous Cell Carcinoma of the Head and Neck · Sponsor: Cliniques universitaires Saint-Luc- Université Catholique de Louvain
The investigators will collect plasma samples at baseline, during treatment, and at progression.
This description comes directly from the study's public registry record.
Jean-Pascal Machiels, MD, PhD · 0032 2 764 · jean-pascal.machiels@uclouvain.be
Séverine Carlier, MD · 0032 2 764 · severine.carlier@uclouvain.be
Always discuss trial participation with your own doctor first.
| Clinique Saint-Pierre | Ottignies, Brabant Wallon, Belgium | Recruiting |
| Grand Hôpital de Charleroi | Charleroi, Hainaut, Belgium | Recruiting |
| Centre Hospitalier Jolimont-Lobbes-Nivelles-Tubize | Haine-Saint-Paul, Belgium | Recruiting |
| CHU Liège | Liège, Belgium | Recruiting |
| Clinique et Maternité Sainte-Elisabeth | Namur, Belgium | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT02139020